Back to Agenda
TUE Session 1: WELCOME AND INTRODUCTION TO THE NEW CLINICAL TRIALS LEGISLATION
Session Chair(s)
Nick Sykes, MS
Policy Advisor, Regulatory Strategy
EFPIA, Belgium
Introduction to the Workshop
Speaker(s)
Introduction to the Workshop
Sabine Atzor, MPHARM, RPH
F. Hoffmann-La Roche Ltd, Switzerland
Head of EU Regulatory Policies
Keynote speech: The New Regulation – How will the outcome reflect the need of Europe?
Fergus Sweeney, PHD
European Medicines Agency, Netherlands
Head of Clinical Studies and Manufacturing Task Force
Keynote speech: Does the new Regulation meet the needs of the innovative industry in a global environment?
Susan Forda, PHD
Eli Lilly & Company Ltd., United Kingdom
VP, GLobal Regulatory Affairs International
Have an account?